La vacuna contra la covid-19 no debe ser obligatoria
The Conversation,
Las vacunas contra la covid-19 ya están llamando a la puerta. En breve, será posible empezar a distribuirlas.
Las vacunas contra la covid-19 ya están llamando a la puerta. En breve, será posible empezar a distribuirlas.
London - AstraZeneca and Oxford University on Wednesday acknowledged a manufacturing error that raised questions about…
Expert sees "nothing sinister" amid questions over Oxford vaccine trial data November 26, 2020 / 1:27 PM U.S.
Kate Bingham, a UK government official, after being vaccinated in London in October 2020.
26/11/2020, 18:58 AstraZeneca's CEO admitted Friday that the company's vaccine needs further study, after a bruising round of…
Kirsty O’Connor/PA Images via Getty ImagesKate Bingham, a UK government official, after being vaccinated in London in October…
Oxford University and AstraZeneca announced on Monday that their vaccine works — but the story soon got messy.
The half-dose/full dose puzzle in the results is explained. Nov 26 · 6 min read The researchers at AstraZeneca and Oxford…
Uitgerekend over het Oxfordvaccin rijzen nu vragen. Het veelbelovende Europese middel dat ons moet beschermen tegen het…
Les résultats offerts par le vaccin Oxford-AstraZeneca contre le coronavirus sont encourageants, mais ils viennent avec une…
Jakarta, CNN Indonesia -- Sebagian pihak ternyata meragukan klaim kemanjuran vaksin corona AstraZeneca 70 persen efektif…
An AstraZeneca boss has dismissed claims Oxford University's coronavirus vaccine is based on 'shaky science' and insisted the…
AstraZeneca est la dernière entreprise pharmaceutique en date à avoir annoncé, lundi 23 septembre, l’obtention de résultats…
Some trial participants only got a partial dose of AstraZeneca’s vaccine. Experts said the company’s spotty disclosures have…
(AGENPARL) – CAMBRIDGE (UNITED KINGDOM), mer 25 novembre 2020 We now have at least preliminary data suggesting how effective…
S'identifier Rechercher Auteur de l'article: Sarah Ugolini, publié le 25/11/2020 à 16:32 Si Pfizer et BioNTech, Moderna…
Alberta imposes state of public health emergency, tightening restrictions across province The latest: Alberta Premier Jason…
While COVID-19 is showing no signs of stopping, we’re hopeful, since several vaccines have gone ahead and showed high…
Hilda Bastia n 11.25.2020 08:00 AM There's been even more good news this week, this time from the Oxford-AstraZeneca trials.
We now have at least preliminary data suggesting how effective the first crop of Covid-19 vaccines will be.
AstraZeneca en de Universiteit van Oxford kondigden deze week aan dat hun coronavaccin zeer effectief is, nadat Moderna en…
Recent news from global COVID-19 vaccine clinical trials have been encouraging, however we are only at the beginning of the…
ANALYSIS: AstraZeneca has become the latest pharmaceutical company to reveal promising results in clinical trialsfor its viral…
Share on Pinterest This is the third experimental COVID-19 vaccine to show promise.
The long-awaited early results from the University of Oxford and AstraZeneca's COVID-19 vaccine trials are in - and experts are…
Good news for older adults in Covid-19 vaccine trial "It is essential that a COVID-19 vaccine can be effective across a broad…
For Immediate Release Chicago, IL – November 24, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog.
(AGENPARL) – CAMBRIDGE (UNITED KINGDOM), mar 24 novembre 2020 Interim results from phase 3 trials of the Covid-19 vaccine from…
For Immediate Release Chicago, IL – November 24, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog.
For Immediate Release Chicago, IL – November 24, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog.
प्रतीकात्मक तस्वीर/ लैब के अंदर की तस्वीर/Twitter | @SerumInstIndia Text Size: A- A+ नई दिल्ली: ऐसा लगता है कि पूरा साल कोरोनावाय…
Oxford COVID-19 Vaccine Producing Strong Immune Response In Elderly Are you aware of the latest pharmacopoeia changes? Early…
The Oxford-AstraZeneca vaccine candidate is 70% effective, on average, according to a press release published on Monday.
The Oxford-AstraZeneca vaccine candidate is 70% effective, on average, according to a press release published on Monday.
Oxford-AstraZeneca's vaccine could be given at half-dose initially. VINCENZO PINTO/AFP via The Oxford-AstraZeneca vaccine…
Oxford-AstraZeneca's vaccine requires two shots. Early results suggest it's more effective if you receive a half dose for the…
The Oxford-AstraZeneca vaccine candidate is 70% effective, on average, according to a press release published on Monday.
The Oxford-AstraZeneca vaccine candidate is 70% effective, on average, according to a press release published on Monday.
For the third consecutive Monday, a drugmaker said its coronavirus vaccine candidate was successful in late-stage studies.
A lower initial dose of the Oxford-AstraZeneca vaccine, would mean double the number of vaccine doses available, once…
VINCENZO PINTO/AFP via Getty ImagesA lower initial dose of the Oxford-AstraZeneca vaccine, would mean double the number of…
For the third consecutive Monday, a drugmaker said its coronavirus vaccine candidate was successful in late-stage studies.
News information is not all-inclusive and updates are published once a week on Tuesdays.
Cheap and fridge-stable candidate at least 60% and up to 90% effective at preventing disease Interim results from phase 3…
Credit: Shutterstock AstraZeneca has become the latest pharmaceutical company to reveal promising results in clinical trials…
Tra i più promettenti vaccini candidati anti contro il coronavirus SARS-CoV-2 vi è sicuramente quello dell’Università di Oxford…
La farmacéutica AstraZeneca presentó un reporte preliminar sobre la eficacia de la vacuna contra el coronavirus que está…
AstraZeneca’s new clinical trial results are positive but confusing, leaving many experts wanting to see more data before…
Related Video and Audio Got a TV Licence? You need one to watch live TV on any channel or device, and BBC programmes on iPlayer.
When clinical trials report their results — and the media follow — the correct term is “efficacy”, rather than “effectiveness”.
К середине ноября 2020 года — спустя восемь месяцев после того, как ВОЗ объявила о начале пандемии COVID-19 — уже четыре разработ…
AstraZeneca has become the latest pharmaceutical company to reveal promising results in clinical trials, for its viral vector…
New Delhi: As an entire year seems to have been lost to coronavirus, all eyes are on 2021 to answer some big questions about…
New Delhi: As an entire year seems to have been lost to coronavirus, all eyes are on 2021 to answer some big questions about…
Product Development Nov 24, 2020 | 2:00 AM GMT Phase III data from a third COVID-19 vaccine, AstraZeneca’sAZD1222,shed more…
Vacúnese contra la gripe: podría protegerlo de una COVID grave Immunogenicity similar across age groups; vaccine better…
"Immunisation with ChAdOx1 nCoV-19 results in the development of neutralising antibodies against SARS-CoV-2 in nearly 100 per…
Follow Us The i newsletter latest news and analysis UK’s Medicines and Healthcare products Regulatory Agency will now assess if…
More than 150 coronavirus vaccines are in development across the world—and hopes are high to bring one to market in record time…
I dati di efficacia annunciati sono preliminari e la ricerca prosegue. Con mezza dose seguita da una dose intera il vaccino…
Die Wirksamkeit des Corona-Impfstoffs von AstraZeneca erscheint mit 70 Prozent vergleichsweise gering.
News of the COVID-19 vaccine has been dominating news headlines and giving people around the world a sliver of hope before the…
MONDAY, Nov. 23, 2020 (HealthDay News) -- The novel chimpanzee adenovirus-vectored vaccine, ChAdOx1 nCoV-19, is well tolerated…
MONDAY, Nov. 23, 2020 -- The novel chimpanzee adenovirus-vectored vaccine, ChAdOx1 nCoV-19, is well tolerated, especially among…
Children play in Dove Lane, in the old town of Tuancheng in Hotan, Xinjiang Uygur autonomous region.
Although there was quite a bit of clinical trial news overall, the biggest focus was on COVID-19 vaccines, with the three…
In reporting that its coronavirus vaccine reached up to 90% efficacy in clinical trials, AstraZeneca and Oxford University also…
Children play in Dove Lane, in the old town of Tuancheng in Hotan, Xinjiang Uygur autonomous region.
Автор: 1 минута В финальных клинических испытаниях вакцины AZD1222, проходивших в Великобритании и Бразилии, участвовало 20 тысяч…
Months ago, U.S. government regulators called for COVID-19 vaccines to have an efficacy of at least 50%, meaning the drugs…
Neben den Impfstoffen von Biontech und Pfizer meldet Astrazeneca ebenfalls ein wirksames Mittel gegen Corona.
efficace al 70% il vaccino messo a punto dall'Universit di Oxford con la casa farmaceutica AstraZeneca e la collaborazione dell'i…
Coronavirus Mit dem britisch-schwedischen Pharmakonzern AstraZeneca hat ein weiteres Unternehmen positive Daten zu einem…
Coronavirus Mit dem britisch-schwedischen Pharmakonzern AstraZeneca hat ein weiteres Unternehmen positive Daten zu einem…
The University of Oxford and AstraZeneca released positive results for their COVID-19 vaccine on Monday.
Carol Smiljan/NurPhoto via Getty Images The University of Oxford and AstraZeneca released positive results for their COVID-19…
Researchers said the trial of more than 20,000 volunteers showed the vaccine stopped people from developing symptoms about 70…
The University of Oxford and AstraZeneca released positive results for their COVID-19 vaccine on Monday.
China's family planning policy is expected to be further relaxed over the next five years and beyond, with extensive social and…
Please Note The Washington Post is providing this important information about the coronavirus for free.
Children play in Dove Lane, in the old town of Tuancheng in Hotan, Xinjiang Uygur autonomous region.
据哥伦比亚新闻网等多家媒体报道,阿斯利康与牛津大学在《柳叶刀》杂志发布新冠疫苗实验数据,结果显示疫苗安全,可引发人体产生强大的免疫反应,而且老年人群的对病毒的耐受性似乎更好。 数据显示,ChAdOx1疫苗临床二期研究共涉及560名成年人,特别是包含240名7…
Alberta set another single-day record on Saturday, again, with 1,336 new COVID-19 cases The latest: New numbers are expected to…
Sinopharm has yet to comment which vaccines were used in the emergency program and Jingzhen was unclear about which vaccine he…
Oxford-AstraZeneca vaccine shows promise in elderly, trial results by Christmas Almost one million people have taken an…
Oxford Vaccine Safe And Effective In Older Adults As Well, Phase 2 Data Shows Researchers said the findings from large, late-stag…
Alberta set another single-day record on Friday with 1,155 new COVID-19 cases The latest: New numbers are expected to be…
COLOMBO (NEWS 1st): The race to develop a COVID-19 vaccine is currently intensifying.
G1 mostra quais são os resultados já apresentados por cada uma das 3 vacinas em acordo com o governo do Brasil: CononaVac…
Space to play or pause M to mute left and right arrows to seek up and down arrows for In a statement, the Lancet said that…
By Nancy Lapid Nov 20 (Reuters) – The following is a roundup of some of the latest scientific studies on the novel coronavirus…
By Nancy Lapid (Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and…
Childhood vaccine linked to less severe COVID-19, cigarette smoke raises risk (Reuters) – The following is a roundup of some of…
The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and…
By Nancy Lapid (Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and…
(Reuters) – The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find…